HE009
/ Nanchang Helioeast Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 06, 2025
Pharmacokinetics, pharmacodynamics, and safety of HE009, a novel selective S1P1 receptor modulator, in healthy Chinese subjects.
(PubMed, Expert Opin Investig Drugs)
- P1 | "The trial was registered on the ChineseClinical Trial Registry, (Identifier No. ChiCTR2200066345), Registered December1, 2022."
Journal • PK/PD data • Cardiovascular • Hypertension • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus • S1PR1
1 to 1
Of
1
Go to page
1